Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors
Clinical trial NCT05081180 · TERMINATED
Trial details
- NCT number
- NCT05081180
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2026-02-11
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.